Dendritic cell-based therapy in Type 1 diabetes mellitus.
about
Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity.Teplizumab therapy for type 1 diabetes.Drug delivery technologies for autoimmune disease.Novel findings in drug-induced dendritic cell tolerogenicity.Dendritic cell therapy for Type 1 diabetes suppression.Breakthrough in diabetes therapy ... Just around the corner?Tolerogenic dendritic cells for Type 1 diabetes.
P2860
Q34730167-9ECE9ADF-9542-4A63-B468-2BF7F92334D7Q37679927-DDE02F70-A1FA-46BB-9582-D42E8C2E98E5Q37801381-2A9423FE-9C42-489A-A2EA-E7E4EC66D5B5Q37809070-F8351DD3-4605-4FE8-9683-F175F17E3EE7Q38059518-D4B493AD-0164-4D4D-8991-6EA9FE9A6CC1Q42646228-DAC92A4D-9720-497B-B1D0-45E0C4AC641BQ46742418-29C91B93-3BF5-481B-ACF6-FBF0E040E802
P2860
Dendritic cell-based therapy in Type 1 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dendritic cell-based therapy in Type 1 diabetes mellitus.
@en
Dendritic cell-based therapy in Type 1 diabetes mellitus.
@nl
type
label
Dendritic cell-based therapy in Type 1 diabetes mellitus.
@en
Dendritic cell-based therapy in Type 1 diabetes mellitus.
@nl
prefLabel
Dendritic cell-based therapy in Type 1 diabetes mellitus.
@en
Dendritic cell-based therapy in Type 1 diabetes mellitus.
@nl
P2093
P2860
P356
P1476
Dendritic cell-based therapy in Type 1 diabetes mellitus.
@en
P2093
Brett Phillips
Massimo Trucco
Nick Giannoukakis
P2860
P304
P356
10.1586/ECI.09.8
P577
2009-05-01T00:00:00Z